secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001683168-26-000027
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals grants annual equity to executives and directors
-----------------------------------------------------------------------

- Non-employee directors each received 10,000 options at $3.68, vesting in 3 equal annual tranches.
- CEO Amy Trombly received 10,000 RSUs vesting on the third anniversary or upon change of control.
- CFO Jerry Dvonch received 5,000 RSUs vesting on the third anniversary or upon change of control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826000027/0001683168-26-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826000027/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer